An open-label treatment use protocol of cyclosporine [ciclosporin] inhalation solution in lung transplant recipients
Phase of Trial: Phase III
Latest Information Update: 14 Sep 2012
At a glance
- Drugs Ciclosporin (Primary)
- Indications Lung transplant rejection
- Focus Registrational; Therapeutic Use
- Sponsors APT Pharmaceuticals Inc
- 14 Sep 2012 Expanded access is no longer available, according to the ClinicalTrials.gov record.
- 01 Apr 2008 New trial record.